Herbal supplement to prevent bladder cancer recurrence
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests a herbal formula called LCS103 to see if it can help prevent bladder cancer from coming back after a tumor has been removed. It is for people with non-invasive bladder cancer that has been fully taken out by surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with a type of bladder cancer that hasn't spread into the muscle layer (non-muscle invasive) and the tumor was fully removed within the last 3 months.
- You are not pregnant and do not plan to become pregnant during the study.
- You have not had any other active cancer (except certain skin cancers) in the past 2 years.
- You are able to swallow tablets and you expect to live at least 5 more years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug called UGN-501, given directly into the bladder through a catheter, for people whose bladder cancer (non-muscle invasive) has returned after previous treatments. It aims to find the right dose and see if it helps control the cancer.
This trial tests a new ablation therapy (a treatment that destroys tumors without surgery) in people with low-grade, non-invasive bladder cancer that comes back. It aims to see if this therapy can help avoid repeated surgeries.
This trial tests a new drug (FL115) given directly into the bladder, alone or with BCG, for people with a type of bladder cancer that has not responded to BCG therapy. It aims to find a better treatment option for those who cannot have or refuse bladder removal surgery.
This trial tests a new drug, SIM0237, alone or with BCG, for people with a type of bladder cancer called non-muscle invasive bladder cancer (NMIBC) that did not respond to BCG treatment. The goal is to see if it is safe and works against the cancer.
This trial tests STM-416, given around the time you have surgery to remove recurring bladder tumors, to see if it can reduce the chance the cancer comes back. It is for people with high-risk early bladder cancer (non–muscle-invasive) who have already had standard treatment and now need another TURBT.
This trial tests whether a diet rich in cruciferous vegetables (like broccoli, cauliflower, and kale) can help prevent bladder cancer from coming back or getting worse. It is for people with early-stage, non-invasive bladder cancer who live in New York State.
Hear when a new Non-muscle Invasive Bladder Cancer (NMIBC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.